Replies to post #133132 on Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

I have explained that the Prurisol Phase 2 results coming within 6 months will catapult the stock to $4. The stock will spend no time between $2 and $4 so the uplist criteria discussion is moot. That's assuming the Kevetrin results won't get us above $2, which, I believe they won't.